CONTENTS:
- A place-based spatial analysis of racial inequities in overdose in St. Louis County Missouri, United States. Marotta P.L., Leach B.C.B., Hutson W.D., Caplan J.M., Lohmann B., Hughes C., et al., art. 104611.
- Frequency is not enough: Characterizing heterogenous patterns of cannabis use intensity among reservation-area American Indian youth. Crabtree M.A., Stanley L.R., Prince M.A., Swaim R.C., art. 104617.
- Cannabis legalization and changes in cannabis and tobacco/nicotine use and co-use in a national cohort of U.S. adults during 2017-2021. Pravosud V., Glantz S., Keyhani S., Ling P.M., Lempert L.K., Hoggatt K.J., et al., art. 104618.
- The role of prescribed controlled substance acquisition as potential triggers of opioid overdose: A case-crossover study. Smith A.M., Peng C., Porter A., Martin B.C., art. 104620.
- Clinical and public safety risks associated with cannabis legalization and frequency of cannabis use among forensic mental health patients. Penney S.R., Jones R.M., Wilkie T., Gerritsen C., Chatterjee S., Chaimowitz G.A., et al., art. 104622.
- Social forces shaping evidence production: A study of the Swiss cannabis pilot trials. Sznitman S.R., Auer R., Havinga J.C., Casalini A., Broers B., art. 104623.
- 'It's not just a matter of taking the drug. It's about changing the way you function in your society too': Narratives of power and resistance in the lived experiences of opioid agonist therapy consumers in regional Victoria, Australia. Patil T., Mummery J., art. 104625.
- Developing a mobile-based brief intervention to reduce cannabis-impaired driving among youth: An intervention mapping approach. Colonna R., Tucker P., Mandich A., Alvarez L., art. 104626.
- Framework for opioid use disorder screening and diagnosis in carceral settings. Jack H.E., Smith C.L., Brinkley-Rubinstein L., Berk J., art. 104627.
- Co-designing the INHSU Prisons Hepatitis C Advocacy Toolkit using the Advocacy Strategy Framework. Walker S.J., Dawson O., Sheehan Y., Shrestha L.B., Lloyd A.R., Sheehan J., et al., art. 104628.
- Creating a robust coordinated data and policy framework for addressing substance use issues in the United States. Chen Q., Sterner G., Rhubart D., Newton R., Shaw B., Scanlon D., art. 104629.
- Recreational cannabis excise taxation in the USA: Constructing a comparable tax measure for empirical analysis. Park H., Yoon D.W., Yang Q., He Y., Han B., Shi Y., et al., art. 104630.
- "They talk about it like it's an overdose crisis when in fact it's basically genocide": The experiences of Indigenous peoples who use illicit drugs in Vancouver's Downtown Eastside neighbourhood. Lavalley J., Steinhauer L., Bundy D., Kerr T., McNeil R., art. 104631.
- Increases in employment over six months following Khanya: A secondary analysis of a pilot randomized controlled trial of a peer-delivered behavioral intervention for substance use and HIV medication adherence in Cape Town, South Africa. Belus J.M., Regenauer K.S., Lu T., Murphy S.M., Rose A.L., Ochieng Y.A., et al., art. 104632.
- Impacts of the COVID-19 pandemic on the availability and retail price of unregulated drugs in Vancouver, Canada: An interrupted time-series analysis, 2018-2022. Swaich A., Ignatieff D., Milloy M.J., Choi J., Kerr T., Hayashi K., art. 104633.
- Substance use as a public health issue: A critical review of the Canadian literature, 1896-2020. Crépault J.-F., Emerson B., Hyshka E., Strike C., Room R., Rehm J., art. 104634.
- High hepatitis C virus reinfection in a community-based sample of people who inject drugs in Imphal, India. Gunaratne M.P., Kedar A., McFall A.M., Srikrishnan A.K., Chingtham S., Amrose P., et al., art. 104635.
- Examining the association between trenbolone, psychological distress, and aggression among males who use anabolic-androgenic steroids. Piatkowski T., De Andrade D., Neumann D., Tisdale C., Dunn M., art. 104636.
- Uncorking the 'wine mum': Exploring the complexity of Australian women's everyday lives and drinking practices. Caluzzi G., Cook M., Patsouras M., Wright C.J.C., Kuntsche E., Kuntsche S., art. 104637.
- Bridging the gap: Exploring consumer experiences and motivations for transitioning between illicit and regulated cannabis markets. Donnan J.R., Howells R., Farooq S., Maillet M., Harris-Lane L.M., art. 104644.
- "Tethered to this ball and chain": Women's perspectives on bodily agency within opioid treatment programs. McCracken A., Brant K., Latkin C., Jones A., art. 104645.
- Drug use patterns and health problems among people who use drugs in Guinea-Bissau (2022): A cross-sectional survey using respondent-driven sampling. Scheibe A., Teixeira A., Aliu Djalo M., Pereira M.N., Barreto K.R., Ba I., et al., art. 104648.
- How does climate change impact people who use alcohol and other drugs? A scoping review of peer reviewed literature. MacLean S., de Nicola J., Cooper K., Downey H., Theobald J., de Kleyn L., et al., art. 104649.
- The criminal careers of Australian drug traffickers. Weatherburn D., Farrell M., Wan W.-Y., Rahman S., art. 104650.
- Bridging the gap: An environmental scan of post-overdose program features and evaluation measures. Ferg M., Rapisarda S.S., Soranno E., Lewis N., Ottoson A., Tschampl C.A., art. 104651.
- Gabapentinoids: Considerations on their contextual harmfulness and psychological dependence potential. Bonnet U., art. 104655.
- Opioid agonist treatment programs and hepatitis C virus elimination in Taiwan: Ways of expanding the care cascade in screening and treatment. Chung Y.-C.E., Tseng C.-I., Wang S.-C., Huang C.-L., Chen L.-Y., Pwu R.-F., et al., art. 104658.